Which has grown faster, ADMA or MRVI?

Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus MRVI at -17.68%.

Is ADMA or MRVI more profitable?

ADMA runs the higher net margin — ADMA at 32.98% versus MRVI at -37.07%.

How have ADMA and MRVI total returns compared?

Over the past 5 years, ADMA delivered 54.74% and MRVI delivered -27.63% annualized total return. Past performance doesn't predict future results.

ADMA Biologics, Inc. (ADMA) vs Maravai LifeSciences Holdings, Inc. (MRVI)

A side-by-side comparison of ADMA Biologics, Inc. and Maravai LifeSciences Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADMA

ADMA Biologics, Inc.

$2.36B

$10.17HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT

MRVI

Maravai LifeSciences Holdings, Inc.

$2.20B

$7.98HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT

Total return — ADMA vs MRVI

growth of $100 · dividends reinvested · last 6y

ADMA +437.8% (+32.4%/yr)MRVI -71.5% (-18.9%/yr)ADMA compounded faster over this window

Log scale — wide-divergence pair

ADMA MRVI

ADMA vs MRVI: by the numbers

•ADMA is the larger company ($2.36B vs $2.20B market cap).
•ADMA is profitable (32.98% net margin) while MRVI runs a net loss (-37.07%).
•ADMA grew revenue faster over the past five years (54.55% vs -17.68% CAGR).

Metrics side by side

Valuation

Metric	ADMA	MRVI
P/E ratio	14.53	N/A
Forward P/E	12.77	N/A
P/S ratio	4.60	10.56
P/B ratio	5.77	10.77
EV / EBITDA	10.73	15.26
FCF yield	4.94%	N/A

Profitability

Metric	ADMA	MRVI
Gross margin	64.71%	17.98%
Operating margin	42.26%	-3.63%
Net margin	32.98%	-37.07%
ROE	41.39%	-37.82%
ROIC	27.60%	16.96%

Growth (annualized)

Metric	ADMA	MRVI
Revenue CAGR (5Y)	54.55%	-17.68%
Total return CAGR (5Y)	54.74%	-27.63%

Frequently asked

Which has grown faster, ADMA or MRVI?: Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus MRVI at -17.68%.
Is ADMA or MRVI more profitable?: ADMA runs the higher net margin — ADMA at 32.98% versus MRVI at -37.07%.
How have ADMA and MRVI total returns compared?: Over the past 5 years, ADMA delivered 54.74% and MRVI delivered -27.63% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ADMA analysis Full MRVI analysis Interactive comparison tool

Dig into the metrics

ADMA Biologics P/E ratio ADMA Biologics ROE Maravai LifeSciences ROE ADMA Biologics operating margin Maravai LifeSciences operating margin ADMA Biologics revenue growth Maravai LifeSciences revenue growth ADMA Biologics free cash flow Maravai LifeSciences free cash flow

ADMA Biologics & Maravai LifeSciences appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.